19

Jul

2018

Prime Therapeutics: Food and Drug Administration Valsartan Recall Notice

July 18, 2018

July 18, 2018

Effective July 13, 2018, the Food and Drug Administration (FDA) issued a recall notice on pharmaceuticals containing the active ingredient Valsartan.

9

Jul

2018

OptumRx: UPDATED FLU SEASON COMMUNICATION 2018-2019

July 6, 2018

Dear Pharmacy Provider:

OptumRx appreciates your pharmacy’s current participation in the Commercial and Medicaid pharmacy networks administered by OptumRx.

9

Jul

2018

Magellan: NOTICE OF NEW FLORIDA LAW: HOUSE BILL (HB) 21

Effective 07/01/2018

 

Dear [Provider/Pharmacist]:

 

Thank you for your quality service and continued care for the wellbeing of our members. As part of an ongoing effort to combat the nationwide opioid overdose epidemic, Governor Rick Scott has signed House Bill (HB) 21 into law, which generally limits opioid prescriptions to a three day supply. This new Florida law will be in effect starting July 1, 2018.

6

Jul

2018

Prime Therapeutics: Processing Reminder for Blue Cross Blue Shield of Alabama Immediate Release Opioids Initial Fill Limit

July 5th, 2018

Dear Valued Provider,

On April 1, 2018, Blue Cross Blue Shield of Alabama ("BCBSAL") implemented a utilization management program which limits the duration of therapy of immediate release opioids (single and combination agents).

First 2345 Last